Durogesic DTrans in children

The prescribing information for Durogesic DTrans (fentanyl) transdermal patch has been updated to include new information about use in paediatric patients.

Durogesic DTrans patches can be used in opioid-tolerant patients aged two to 16 years who are already receiving at least 30mg oral morphine equivalent per day. Patches should be applied to the upper back to minimise the chances of the child removing them and patch adhesion should be monitored closely.

New warnings state that the product must not be administered in opioid-naïve children, and the potential for serious or life-threatening hypoventilation exists regardless of the dose.

Further information: Janssen-Cilag 01494 567444


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases